Status:
WITHDRAWN
Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations
Lead Sponsor:
Queen Mary University of London
Conditions:
Acute Respiratory Infection
Asthma Exacerbations
Eligibility:
All Genders
16+ years
Phase:
PHASE2
Brief Summary
REMASK trial is a Trial within Cohort study (TwiCs), nested within the COVIDENCE UK longitudinal study. It has been designed to determine whether the offer of a free reusable, elastomeric face mask to...
Eligibility Criteria
Inclusion
- Eligibility criteria, participants with asthma ('index participants'):
- Aged 16 or more years
- Doctor diagnosis of asthma
- Current prescription for treatment of asthma
- Participant in COVIDENCE UK nasal swab study
Exclusion
- Regularly using any FFP-rated face mask when in an indoor public place
- Currently sharing household with one or more children
- Currently sharing household with one or more other COVIDENCE UK participants who have asthma
- Unable to tolerate wearing face mask
- Eligibility criteria, household members of index participants:
- Inclusion criteria
- Age 16 or more
- Living in same household as index participant who has consented to take part in trial
- Exclusion criteria
- \- Unable to tolerate wearing face mask
Key Trial Info
Start Date :
March 27 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06885229
Start Date
March 27 2025
End Date
April 1 2025
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary University of London
London, Greater London, United Kingdom